ASS1, another key enzyme in UC, not only promoted the growth and invasion of gastric cancer (Tsai et al., 2018) and colorectal cancer (Doubleday et al., 2021), but also inhibited the progression of HCC (Kim et al., 2021). Here, ASS1 is linked to hepatocellular carcinoma.